The patient sat at the home office desk on Saturday morning with three lists in front of them. The medication list, photocopied from the primary care chart. The smoking history list, with the year of quit-day circled. The weight log, with the last twelve months of monthly numbers. The patient was preparing for the consultation that had been scheduled for the following Wednesday, and had decided to do the candidacy self-evaluation work in advance rather than discover the disqualifying factors only during the consultation. The orthopedist had mentioned that some patients are not candidates for the procedure. The patient wanted to know which factors made the difference and whether they applied.
This guide is for that Saturday morning self-evaluation. Candidacy for stem cell therapy depends on several medical and lifestyle factors that consultations evaluate before recommending the procedure. The patient who has reviewed these factors before the appointment usually has a clearer conversation than the patient who has not.
Which Medical Conditions Generally Disqualify Candidates
A short list of medical conditions that frequently disqualify candidates from stem cell therapy in current clinical practice:
- Active malignancy (cancer currently under treatment)
- Recent cancer history within a defined window, with specifics depending on cancer type and treatment
- Active systemic infection at the time of procedure
- Severe organ dysfunction including advanced kidney disease, advanced liver disease, or severe cardiac disease
- Uncontrolled diabetes with significant vascular complications
- Pregnancy or active breastfeeding
- Active autoimmune conditions in unstable phase, depending on specific condition and treatment status
- Bleeding disorders or anticoagulant therapy that cannot be safely managed around the procedure
- Severe immunocompromise from disease or medication
The published research at NIH PubMed Central documents that approximately 20 to 30 percent of applicants for stem cell treatment at qualified international centers are denied during pre-screening due to disqualifying underlying health factors, which suggests the candidacy bar is meaningful even when patients self-select for evaluation.
The patient with one of these conditions should know that the disqualification is generally about safety and likely response, not about the patient’s worthiness for treatment. A clinic that recommends stem cell therapy to a patient with these factors without addressing them is operating below the candidacy-evaluation standard the procedure deserves.
How Age and Body Weight Influence Treatment Response
Age and body weight are two factors clinics consistently evaluate during candidacy assessment:
Age considerations. Younger patients (typically under 65) have generally shown more favorable response patterns in published studies for several stem cell applications. The body’s intrinsic regenerative capacity declines with age, and the response to regenerative intervention often follows the same trajectory. Patients over 75 or 80 may have more limited response potential, though individual variation is substantial and chronological age is not the same as biological age.
Body weight considerations. The CDC adult BMI framework provides standardized assessment of body weight category. Body mass index correlates with several factors that affect stem cell therapy candidacy and response:
- Higher BMI is associated with chronic systemic inflammation, which may affect local tissue response
- Mechanical loading on joints scales with body weight, which affects whether regenerative intervention can shift the trajectory
- Surgical and procedural risks generally increase with higher BMI
- Recovery and rehabilitation engagement may be more challenging at certain BMI ranges
Patients with elevated BMI may still be candidates, particularly with engaged weight management as part of the overall treatment plan. Patients at very low BMI may also face candidacy considerations related to nutritional status and tissue health. The clinic that asks about weight history and current BMI is gathering relevant clinical information rather than making judgments.
How Smoking, Alcohol, and Medication Factors Affect Eligibility
Lifestyle factors that affect stem cell therapy candidacy include several documented in the published research at NIH and CDC:
Smoking and tobacco use. Active smoking is associated with reduced wound healing, impaired vascular function, and reduced response to regenerative interventions. Many clinics ask patients to discontinue smoking for a defined window before the procedure, with some clinics requiring smoking cessation as a candidacy criterion.
Alcohol consumption. Heavy alcohol use is associated with reduced bone marrow function, immune dysregulation, and impaired tissue healing. Moderate occasional alcohol use is generally not a candidacy issue. Daily heavy alcohol use may require evaluation and reduction before procedure scheduling.
Medication factors that affect candidacy:
- Anticoagulants (blood thinners), which may need adjustment around the procedure window
- NSAIDs (ibuprofen, naproxen, and similar), which are typically held for one to two weeks around the procedure to avoid interfering with the inflammatory pro-repair response
- Corticosteroids, including recent injections at the target site, which may affect candidacy timing
- Immunosuppressants, depending on indication and the specific stem cell protocol
- Some chemotherapeutic agents and biologics, which may have specific timing considerations
The patient should bring a complete medication list to the candidacy consultation, including prescription, over-the-counter, and supplement medications. The full list is what the clinic needs to evaluate the candidacy and procedure planning.
Which Imaging and Diagnostic Workups Inform Candidacy
Imaging and diagnostic studies provide the clinical data that completes candidacy evaluation:
- Joint X-rays, particularly weight-bearing for lower extremity joints, that document joint space, alignment, and structural changes
- MRI for soft tissue assessment, including cartilage pattern, ligament status, and surrounding tissue
- For some applications, ultrasound for dynamic assessment and pre-procedure planning
- Laboratory studies including complete blood count, basic metabolic panel, and (for some protocols) coagulation studies
- For specific conditions, additional studies such as inflammatory markers, autoimmune panels, or condition-specific assays
A clinic that recommends stem cell therapy without reviewing recent imaging is operating below the candidacy-evaluation standard. A clinic that requires updated imaging when prior imaging is older than a defined window is operating at the standard the procedure expects.
Self-Assessment Questions Before Your Consultation
A short list of questions the patient can work through before the candidacy consultation:
- What is my specific diagnosis, and what is the disease stage or grade?
- What conservative treatments have I tried, and what was the response to each?
- What is my current medication list, including over-the-counter and supplements?
- What is my smoking, alcohol, and substance use history?
- What is my current BMI and recent weight history?
- Do I have any active infections, recent cancer history, or significant organ dysfunction?
- What is my realistic timeline expectation, and what level of response would I consider successful?
- What is my insurance coverage and out-of-pocket budget for the procedure?
- Am I able to engage in the post-procedure rehabilitation the protocol requires?
- Do I have support at home for the recovery window?
The patient who has worked through these questions in advance arrives at the consultation with the relevant information at hand, which generally produces a more useful candidacy conversation than reconstructing the information during the appointment itself.
What to Expect During the Formal Candidacy Evaluation
The clinical candidacy evaluation generally includes several components:
- Detailed medical history review, including the conditions and treatments listed above
- Physical examination of the affected joint or condition
- Review of imaging and laboratory studies, with additional studies ordered if needed
- Discussion of conservative treatments tried and the response to each
- Discussion of treatment goals and expected response from stem cell therapy
- Discussion of alternative treatments including conventional medical or surgical options
- Assessment of patient engagement with rehabilitation and follow-up
- Review of financial considerations and insurance position
- Final candidacy determination, with rationale explained to the patient
A consultation that runs through these components in detail is operating at the candidacy-evaluation level. A consultation that recommends the procedure within minutes of meeting the patient, without the diagnostic and lifestyle review, is operating differently. The patient evaluating the consultation experience itself often gathers useful information about whether the clinic’s general practice aligns with the candidacy standard the procedure deserves.
The Saturday morning home office desk that started this guide ends with the three lists organized into a single folder for the Wednesday appointment. The medication, lifestyle, and weight information sit together in a form the consultation can use efficiently. The Wednesday consultation, when it happens, often tends to move faster and more usefully because the candidacy data has been pre-organized than because the data was discovered during the appointment itself.
Important note on candidacy decisions: No clinic selection framework guarantees outcomes, and regional availability and individual candidacy factors shape what each patient encounters. The realistic question is what specific criteria the patient applies to clinic evaluation and what professional input, including primary care, specialist consultation, and second opinion, supports a sound decision.
Sources: